Androgen receptor signaling inhibitors linked to increased risk of cardiovascular adverse events in prostate cancer. Nierengarten MB. Cancer 2024;130:3399.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Androgen receptor signaling inhibitors linked to increased risk of cardiovascular adverse events in prostate cancer. Cancer 2024;130:3399.
PMID: 39327700